SCHEMBL3010381

SCHEMBL3010381

COc1ccc(Cl)cc1S(=O)(=O)C1CCN(c2nc(Cc3ccc(Cl)c(Cl)c3)cs2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
ERBB2 P04626 4/20 0.38
EPHA2 P29317 4/20 0.38
HTT P42858 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDR P35968 3/20 0.37
EPHB4 P54760 3/20 0.37
CPT1A P50416 4/20 0.37
CPT1B Q92523 4/20 0.37
MAPT P10636 3/20 0.37
MAPK1 P28482 1/20 0.37
LMNA P02545 3/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3011794 0.93 MAPT (0.39) TP53KDM4EALDH1A1POLBHPGD
SCHEMBL3019226 0.93 TP53 (0.39) TP53KDM4EALDH1A1POLBHPGD
SCHEMBL3018474 0.93 MAPT (0.40) TP53KDM4EALDH1A1POLBHPGD
SCHEMBL3016294 0.93 MAPT (0.39) TP53KDM4EALDH1A1POLBHPGD
SCHEMBL3012724 0.92 ALDH1A1 (0.41) ALDH1A1POLBHPGDRAB9AERBB2
SCHEMBL3019234 0.92 ERBB2 (0.40) ALDH1A1ERBB2EPHA2KDREPHB4
SCHEMBL3017001 0.92 TP53 (0.40) TP53KDM4EALDH1A1POLBHPGD
SCHEMBL3006331 0.91 TP53 (0.40) TP53KDM4EALDH1A1POLBHPGD
SCHEMBL3016811 0.91 MAPK1 (0.38) TP53KDM4EALDH1A1POLBHPGD
SCHEMBL3011774 0.91 MAPT (0.40) TP53KDM4EALDH1A1POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722681-B2 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases NV REMYND (BE) 2014-05-13 US disclosed
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES SMN1; SMN2, HTT, SNCA TP53 2880/4885KDM4E 4398/4885ALDH1A1 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.